ReviewInternational journal of molecular sciences2025
DNA Damage and Repair in Pancreatic Cancer-The Latest Findings.
Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Age- and Treatment-Specific TP53 and PI3K Alterations in Pancreatic Ductal Adenocarcinoma (PDAC) Revealed by Conversational Artificial Intelligence.International journal of molecular sciences · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Pancreatic cancer is one of the most common cancers of the gastrointestinal tract, alongside stomach and colon cancers, yet remains among the least studied. Due to its non-specific symptoms, late diagnosis, and limited treatment options, it is associated with a poor prognosis and high mortality. Major risk factors for pancreatic cancer include smoking, alcohol consumption, pancreatitis, obesity, and type 2 diabetes. These environmental factors can damage DNA through various mechanisms and, if not properly repaired, may initiate carcinogenesis. DNA repair is one of the key mechanisms in cancer prevention. It has been suggested that impaired DNA repair may contribute to the development and progression of pancreatic cancer. The aim of this review is to highlight the link between environmental factors, DNA damage and DNA repair in pancreatic cancer. Environmental exposures can trigger a cascade of molecular events, including ROS (reactive oxygen species) overproduction, oxidative stress, insulin resistance, hyperglycemia, and inflammation, that lead to DNA damage. Additionally, up to 25% of patients with PDAC (pancreatic ductal adenocarcinoma) carry mutations in DDR (DNA damage response) genes, and only 5% of all cases are hereditary. Therefore, increased DNA damage combined with disturbances in DDR creates a condition accelerating pancreatic cancer progression. Further research should focus on DDR pathways as potential targets for screening and therapy. Such an approach could significantly improve early diagnosis and treatment outcomes. Moreover, uncovering the mechanisms linking pancreatic cancer aggressiveness with DNA repair deficiencies may lead to the development of specific biomarkers, enabling early detection and potentially improving patient survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.